Unlocking AI Success: Lessons from the HealthVerity and AWS Webinar
With advances in artificial intelligence (AI) making headlines almost daily, the life sciences...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists...
With advances in artificial intelligence (AI) making headlines almost daily, the life sciences...
An interview with Kristijan Kahler, executive director of innovation evidence at Novartis While...
Given its role at the intersection of novel real-world data and emerging technologies, HealthVerity...
Our series on how Privacy Preserving Record Linkage (PPRL) technology can help government agencies...
HealthVerity is proud to partner with Inovalon, the largest closed claims data source in the U.S.,...
In our ongoing series on how Privacy-Preserving Record Linkage (PPRL) technology can help...
Healthcare brand marketing is at a crossroads. With patients taking a more active role in their...
One in eight women in the U.S. will be diagnosed with breast cancer in their lifetime, that’s one...
In case you missed it, at the end of August, the FDA released new guidance on how to approach...
In our series on how Privacy-Preserving Record Linkage (PPRL) technology can help government...
Artificial intelligence is moving quickly into healthcare research, but one question still comes up: can you trust it? If an AI platform is going to support study design, cohort definition, analysis and reporting, RWE teams need confidence that the o...